Ultra-Rare Immune System Disease Gets First FDA-Approved Treatment
(MedPage Today) -- The FDA approved pozelimab (Veopoz) as the first treatment for adults and children ages 1 year and up with CD55-deficient protein-losing enteropathy.
Also known as CHAPLE (complement hyperactivation, angiopathic thrombosis... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - August 18, 2023 Category: Gastroenterology Source Type: news
Clot Risk Factors Emerge for Cancer Patients With COVID-19
(MedPage Today) -- Multiple factors were associated with an increased risk for venous thromboembolism (VTE) in hospitalized cancer patients with COVID-19, a registry-based cohort study found.
Pooled together, exposure to commonly used anti-cancer... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - August 17, 2023 Category: Hematology Source Type: news
Adenovirus May Trigger Thrombocytopenia, Thrombosis, Case Studies Suggest
(MedPage Today) -- In rare cases, symptomatic human adenovirus infection may trigger a life-threatening prothrombotic anti-platelet factor 4 (PF4) disorder resembling vaccine-induced immune thrombotic thrombocytopenia (VITT), according to a report... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - August 9, 2023 Category: Cardiology Source Type: news
FAPI-PET predicts treatment response in liver cancer patients
FAPI-PET imaging can predict how patients with unresectable hepatocellular carcinom...Read more on AuntMinnie.comRelated Reading:
PET/CT shows value in patients with portal vein thrombosis
PSMA-PET matches MRI, beats CT in diagnosing liver cancer
CT radiomics helps predict HCC recurrence after liver transplant
New tracer bests FDG for diagnosing liver cancer
PET identifies early responders to liver cancer treatment (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - July 31, 2023 Category: Radiology Source Type: news
Anticoagulants for Cancer-Related VTE: What Works Best? Anticoagulants for Cancer-Related VTE: What Works Best?
Cancer patients with venous thromboembolism should preferentially be given direct oral anticoagulants over other drugs to reduce the risk of major complications, a recent analysis shows.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - July 28, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Routine Thromboprophylaxis for Advanced Ovarian Cancer? Routine Thromboprophylaxis for Advanced Ovarian Cancer?
Two thirds of venous thromboembolism events came during neoadjuvant chemotherapy and might have been prevented with direct-acting oral anticoagulants, a new study suggests.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 24, 2023 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Tenecteplase a First-Line Thrombolytic for LVO Stroke? Tenecteplase a First-Line Thrombolytic for LVO Stroke?
Tenecteplase confers similar reperfusion, safety, and functional outcomes as alteplase in patients with large-vessel occlusion stroke, new research shows.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - July 12, 2023 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news
Anticoagulant use in older persons at risk for falls: therapeutic dilemmas-a clinical review - Mitchell A, Elmasry Y, van Poelgeest E, Welsh TJ.
PURPOSE: The aim of this clinical narrative review was to summarise the existing knowledge on the use of anticoagulants and potential adverse events in older people at risk of falls with a history of atrial fibrillation or venous thromboembolism. The revie... (Source: SafetyLit)
Source: SafetyLit - July 4, 2023 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news
PET/CT radiomics help with multiple myeloma prognosis
Radiomics models based on F-18 FDG-PET/CT imaging features and powered by machin...Read more on AuntMinnie.comRelated Reading:
SNMMI: Experts debate AI's role in nuclear medicine
PET/CT shows value in patients with portal vein thrombosis
SNMMI: PET tracer describes clear cell renal cancer
SNMMI: New technology improves whole-body PET image quality
PET predicts 'dry mouth' side effect in radiotherapy patients (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 30, 2023 Category: Radiology Source Type: news
Highlights on Thrombosis and Hemostasis From EHA 2023 Highlights on Thrombosis and Hemostasis From EHA 2023
Thrombosis and hemostasis highlights from EHA 2023 identify VTE as a major complication in acute promyelocytic leukemia, biomarkers for VTE in lung cancer, and an investigational thrombosis inhibitor.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 29, 2023 Category: Consumer Health News Tags: None ReCAP Source Type: news
Benefits of Indefinite Anticoagulant Unclear After First VTE
THURSDAY, June 29, 2023 -- For patients with a first unprovoked venous thromboembolism (VTE), indefinite anticoagulation prevents some recurrent VTE events but induces additional major bleeding events, according to a study published online June 27... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 29, 2023 Category: Pharmaceuticals Source Type: news
PET/CT shows value in patients with portal vein thrombosis
PET/CT could be a valuable new imaging technique for distinguishing benign fro...Read more on AuntMinnie.comRelated Reading:
Novel PET radiotracer shows promise in cancer imaging
AI developed for PET/CT lung cancer imaging
PET/CT reveals different reactions to COVID-19 vaccines
PET/CT predicts survival in women with inflammatory breast cancer
PET/CT bests bone scintigraphy for detecting invasive breast cancer (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 27, 2023 Category: Radiology Source Type: news
Reducing Risk for Thrombosis in Patients With Lung Cancer Reducing Risk for Thrombosis in Patients With Lung Cancer
Researchers have examined whether treatment with lazertinib-amivantamab entails an increased risk of venous thromboembolism in patients with advanced or metastatic non –small cell lung cancer.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 20, 2023 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Tension pneumomediastinum and coronary artery thrombosis following a motorcycle accident: a case report - Rouleau SG, Manoukian MAC, Wong GX, Barnes DK.
INTRODUCTION: Tension pneumomediastinum and coronary artery thrombosis (CAT) secondary to blunt polytrauma are, rare yet have the potential for serious complication. CASE REPORT: A 40-year-old man presented to the emergency department following a motorcycl... (Source: SafetyLit)
Source: SafetyLit - June 9, 2023 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news
ASCO: Direct Oral Anticoagulant Therapy Feasible for Cancer Patients
TUESDAY, June 6, 2023 -- Direct oral anticoagulant (DOAC) treatment is noninferior to low-molecular-weight heparin (LMWH) for preventing recurrent venous thromboembolism (VTE) in cancer patients, according to a study published online June 2 in the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 6, 2023 Category: Pharmaceuticals Source Type: news
